Educate
Learn with us
Advocate
Discover your voice
Connect
Get involved! Serve on a team
AzPA Pharmacy Flash
- Where Teva failed, Eli Lilly gained — migraine drug Emgality wins US approval for episodic cluster headachesIt may be trailing behind its rivals in migraine sales, but Lilly’s Emgality has secured the FDA nod for episodic cluster headaches. Emgality was the last injectable to win approval for migraine prevention last September, months after Aimovig from Amgen and Novartis, and Teva’s Ajovy. All three form part of a family of drugs developed […]
- New breast cancer drug found to boost survival rates by 30%A new form of drug drastically improves survival rates of younger women with the most common type of breast cancer, researchers said recently, citing the results of an international clinical trial. The findings, presented at the annual meeting of the American Society of Clinical Oncology in Chicago, showed that the addition of cell-cycle inhibitor ribociclib […]
- FDA requests comments on blister packaging for certain opioidsSpecifically, FDA wants to know which opioid or opioid-containing products are appropriate candidates for such packaging. FDA is soliciting feedback through a public docket. The new requirement is part of the SUPPORT Act law, which allows FDA to require special packaging for opioids and other drugs that have the potential for abuse or come with […]
